Trials / Completed
CompletedNCT00545168
Safety and Efficacy Study of NatrOVA Creme Rinse - 1% and NIX Creme Rinse in Subjects 6 Months or Older With Head Lice
A Phase 3 Comparative Safety and Efficacy Study Between NatrOVA Creme Rinse - 1% and NIX Creme Rinse in Subjects > 6 Months of Age With Pediculosis Capitis
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 480 (actual)
- Sponsor
- ParaPRO LLC · Industry
- Sex
- All
- Age
- 6 Months
- Healthy volunteers
- Accepted
Summary
A comparative safety and efficacy study of NatrOVA Creme Rinse - 1% versus NIX Creme Rinse, under actual use conditions in subjects 6 months of age or greater who are infested with Pediculosis capitis (Head lice).
Detailed description
This is a Phase 3 multi-site, randomized, evaluator/investigator-blinded, three-arm, parallel group study evaluating the safety and efficacy of NatrOVA Creme Rinse - 1% (with nit combing and without nit combing) versus NIX Creme Rinse in an "actual use" environment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Spinosad | 10 minute topical application of product, followed by a complete rinse off. |
| DRUG | Spinosad | 10 minute topical application followed by a complete rinse off, followed by a nit combing regimen. |
| DRUG | Permethrin 1% | Topical application for 10 minutes, followed by a complete rinse off, followed by a nit combing regimen |
Timeline
- Start date
- 2007-09-01
- Primary completion
- 2008-03-01
- Completion
- 2008-05-01
- First posted
- 2007-10-17
- Last updated
- 2012-10-11
- Results posted
- 2012-10-11
Locations
6 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00545168. Inclusion in this directory is not an endorsement.